Table 2.
Procedure-related data before and after gradual balloon dilatation of the atrial septum, in nine patients after trans-septal puncture by the Brockenbrough technique.
Patient no. | AS needle (Yes/No) | Procedure (min) | Fluoroscopy (min) + VAT | Balloon size max. (mm) | RAP- pre (mmHg) | RAP-post (mmHg) | PCWP/LAP- pre (mmHg) | LAP-post (mmHg) | SaO2 - post (%) | R/L-shunt at rest (Yes/No/Bi) | Subsequent treatment | AS clinical effect |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Yes | 128 | 14 | 12 | 13 | 11 | 6 | 8 | 90 | Yes | S, SP, B | Short; Stent* |
2 | Yes | 91 | 10 | 8 | 3 | 2 | 3 | 3 | 98 | No | S, A | No syncope |
3 | Yes | 281 | 46 | 12 | 6 | 7 | 8 | 5 | 92 | Bi | S, SP, B, I + Prd | Resusc in Cath. |
4 | Yes | 172 | 11 | 10 | 5 | 6 | 5 | 8 | 97 | No | S, SP, A | No syncope |
5 | Yes | 178 | 27 | 14 | 23 | 21 | 14 | 14 | 82 | Yes | S, SP, A, B | Transient, Potts-S |
6 | Yes | 176 | 19 | 8 | 8 | 11 | 4 | 9 | 93 | Bi | S, SP, B | No syncope |
7 | Yes | 196 | 16 | 8 | 12 | 12 | 12 | 12 | 95 | Bi | S, SP, I | No syncope |
8 | No | 155 | 15 | 8 | 3 | 3 | 3 | 6 | 90 | Bi | S, SP, I, A | No PHC |
9 | Yes | – | – | 14 | 21 | – | – | 20 | 55 | Yes | S, SP, I, B | ASD-Occl 12 mm |
10 | Yes | 210 | 31 | 10 | 4 | 4 | 7 | 7 | 90 | Bi | S, SP, A, Ambrisentan | No syncope |
11 | No | 159 | 9 | 6 | 6 | 5 | 9 | 10 | 99 | No | S, A | No PHC |
Mean | 174.6 | 19.8 | 10 | 9.5 | 8.2 7.1 | 9.3 | 89.2 | |||||
SD (+/-) | 47.8 | 11 | 2.6 | 6.7 | 5.4 3.5 | 4.5 | 11.7 | |||||
Min | 91 | 9 | 6 | 3 | 2 3 | 3 | 55 | |||||
Max | 281 | 46 | 14 | 23 | 21 14 | 20 | 99 | |||||
Median | 174 | 15 | 10 | 6 | 6.5 6.5 | 8 | 92 |
IAS stenting
A, amlodipine; AS, atrioseptostomy; ASD, atrial septum defect; B, Bosentan; Bi, bidirectional shunt; I, Iloprost; LAP, left atrial pressure; Occl, occluder; PCWP, pulmonary capillary wedge pressure; PHC, pulmonary hypertensive crisis; Potts-S, Potts-shunt; Prd, prednisolone; RAP, right atrial pressure; Resusc, resuscitation; R/L, right/left shunt; S, sildenafil; SaO2, arterial oxygen saturation; Sp, spironolactone;